TY - JOUR
T1 - Cardiovascular, respiratory, and related disorders
T2 - key messages from Disease Control Priorities, 3rd edition
AU - Disease Control Priorities-3 Cardiovascular, Respiratory, and Related Disorders Author Group
AU - Prabhakaran, Dorairaj
AU - Anand, Shuchi
AU - Watkins, David
AU - Gaziano, Thomas
AU - Wu, Yangfeng
AU - Mbanya, Jean Claude
AU - Nugent, Rachel
AU - Ajay, Vamadevan S.
AU - Afshin, Ashkan
AU - Adler, Alma
AU - Ali, Mohammed K.
AU - Bateman, Eric
AU - Bettger, Janet
AU - Bonow, Robert O.
AU - Brouwer, Elizabeth
AU - Bukhman, Gene
AU - Bull, Fiona
AU - Burney, Peter
AU - Capewell, Simon
AU - Chan, Juliana
AU - Chandrasekar, Eeshwar K.
AU - Chen, Jie
AU - Criqui, Michael H.
AU - Dirks, John
AU - Dugani, Sagar B.
AU - Engelgau, Michael
AU - El Nahas, Meguid
AU - Fall, Caroline HD
AU - Feigin, Valery
AU - Fowkes, F. Gerald R.
AU - Glassman, Amanda
AU - Goenka, Shifalika
AU - Gupta, Rajeev
AU - Hasan, Babar
AU - Hersch, Fred
AU - Hu, Frank
AU - Huffman, Mark D.
AU - Jabbour, Samer
AU - Jarvis, Deborah
AU - Jeemon, Panniyammakal
AU - Joshi, Rohina
AU - Kamano, Jemima H.
AU - Kengne, Andre Pascal
AU - Kudesia, Preeti
AU - Kumar, R. Krishna
AU - Kumaran, Kalyanaraman
AU - Lambert, Estelle V.
AU - Lee, Edward S.
AU - Li, Chaoyun
AU - Luo, Rong
AU - Magee, Matthew
AU - Malik, Vasanti S.
AU - Marin-Neto, J. Antonio
AU - Marks, Guy
AU - Mayosi, Bongani
AU - McGuire, Helen
AU - Micha, Renata
AU - Miranda, J. Jaime
AU - Montoya, Pablo Aschner
AU - Moran, Andrew E.
AU - Mozaffarian, Dariush
AU - Naicker, Saraladevi
AU - Naidoo, Nadraj G.
AU - Narayan, KM Venkat
AU - Nikolic, Irina
AU - O'Donnell, Martin
AU - Onen, Churchill
AU - Osmond, Clive
AU - Patel, Anushka
AU - Perez-Padilla, Rogelio
AU - Poulter, Neil
AU - Pratt, Michael
AU - Rabkin, Miriam
AU - Rajan, Vikram
AU - Rassi, Anis
AU - Rassi, Anis
AU - Rawal, Ishita
AU - Remuzzi, Giuseppe
AU - Riella, Miguel
AU - Roth, Greg A.
AU - Roy, Ambuj
AU - Rubinstein, Adolfo
AU - Sakuma, Yuna
AU - Sampson, Uchechukwu KA
AU - Siegel, Karen R.
AU - Sliwa, Karen
AU - Suhrcke, Marc
AU - Tandon, Nikhil
AU - Thomas, Bernadette
AU - Vaca, Claudia
AU - Vedanthan, Rajesh
AU - Verguet, Stéphane
AU - Webb, Michael
AU - Weber, Mary Beth
AU - Whitsel, Laurie
AU - Wong, Gary
AU - Yan, Lijing L.
AU - Yancy, Clyde W.
AU - Zhang, Ping
AU - Zhao, Dong
AU - Zhu, Yishan
N1 - Publisher Copyright:
© 2018 Elsevier Ltd
PY - 2018/3/24
Y1 - 2018/3/24
N2 - Cardiovascular, respiratory, and related disorders (CVRDs) are the leading causes of adult death worldwide, and substantial inequalities in care of patients with CVRDs exist between countries of high income and countries of low and middle income. Based on current trends, the UN Sustainable Development Goal to reduce premature mortality due to CVRDs by a third by 2030 will be challenging for many countries of low and middle income. We did systematic literature reviews of effectiveness and cost-effectiveness to identify priority interventions. We summarise the key findings and present a costed essential package of interventions to reduce risk of and manage CVRDs. On a population level, we recommend tobacco taxation, bans on trans fats, and compulsory reduction of salt in manufactured food products. We suggest primary health services be strengthened through the establishment of locally endorsed guidelines and ensured availability of essential medications. The policy interventions and health service delivery package we suggest could serve as the cornerstone for the management of CVRDs, and afford substantial financial risk protection for vulnerable households. We estimate that full implementation of the essential package would cost an additional US$21 per person in the average low-income country and $24 in the average lower-middle-income country. The essential package we describe could be a starting place for low-income and middle-income countries developing universal health coverage packages. Interventions could be rolled out as disease burden demands and budgets allow. Our outlined interventions provide a pathway for countries attempting to convert the UN Sustainable Development Goal commitments into tangible action.
AB - Cardiovascular, respiratory, and related disorders (CVRDs) are the leading causes of adult death worldwide, and substantial inequalities in care of patients with CVRDs exist between countries of high income and countries of low and middle income. Based on current trends, the UN Sustainable Development Goal to reduce premature mortality due to CVRDs by a third by 2030 will be challenging for many countries of low and middle income. We did systematic literature reviews of effectiveness and cost-effectiveness to identify priority interventions. We summarise the key findings and present a costed essential package of interventions to reduce risk of and manage CVRDs. On a population level, we recommend tobacco taxation, bans on trans fats, and compulsory reduction of salt in manufactured food products. We suggest primary health services be strengthened through the establishment of locally endorsed guidelines and ensured availability of essential medications. The policy interventions and health service delivery package we suggest could serve as the cornerstone for the management of CVRDs, and afford substantial financial risk protection for vulnerable households. We estimate that full implementation of the essential package would cost an additional US$21 per person in the average low-income country and $24 in the average lower-middle-income country. The essential package we describe could be a starting place for low-income and middle-income countries developing universal health coverage packages. Interventions could be rolled out as disease burden demands and budgets allow. Our outlined interventions provide a pathway for countries attempting to convert the UN Sustainable Development Goal commitments into tangible action.
UR - http://www.scopus.com/inward/record.url?scp=85032836840&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(17)32471-6
DO - 10.1016/S0140-6736(17)32471-6
M3 - Review article
C2 - 29108723
AN - SCOPUS:85032836840
SN - 0140-6736
VL - 391
SP - 1224
EP - 1236
JO - The Lancet
JF - The Lancet
IS - 10126
ER -